Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked mutation that is more prevalent in African, Asian, Latin American and Mediterranean populations. Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia. Given the potential for coronavirus to trigger oxidative stress, unrecognized G6PD deficiency in the presence of the COVID-19 viral infection may cause hemolytic crisis and worse outcome in affected individuals.

The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?

Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults.

Mental health issues in the elderly.

A practical, clinical approach to the diagnosis of depression in the elderly is described, and guidelines are suggested for treatment of depression by pharmacotherapy, electroconvulsive therapy, and psychotherapy, Clinical dementia is reversible in one-fifth of elderly patients with this disorder. For those with irreversible dementias management of the environment and pharmacotherapy are recommended.